Our latest COVID-19 information - full Autumn programme of webinars now in place

Metered Dose Inhaler (MDI) Technology Training Course

A comprehensive overview of MDIs including development, manufacture, regulation and market potential

16-17 Feb 2021

& 18-19 Feb 2021 , 13-14 Sep 2021 , 15-16 Sep 2021

Book now

Details

Course overview

This interactive seminar will provide a comprehensive overview of metered-dose inhaler technology, giving participants a valuable insight into market potential and recent industry trends. The programme will clarify the therapeutic targets and look at the various delivery technologies available. There will be detailed coverage of the manufacturing process, equipment and options, together with quality and inspection requirements, human factors and bioequivalence. Our highly experienced trainer will address the regulations applying to inhalation products and provide guidance on the regulatory pathways to follow.

The event will benefit those new to this area and will also be of value to anybody who requires a refresher on the opportunities available with this technology. The seminar format will include practical workshops, which past delegates have found invaluable, and ample opportunity for discussion on any specific issues with an expert in this field.

Media Partner

Inhalationlogo

Who should attend?

  • Respiratory pharma professionals who need to understand MDI technology and its opportunities
  • Medical device professionals new to working in the area of MDIs or those who need a refresher
  • Medical device business development managers
  • Respiratory professionals in R&D
  • Medical device manufacturers working in the respiratory market

Presenter

David Howlett (More...)

In 2003 David established PharmaDelivery Solutions Ltd as a specialised consultancy service in the field of drug delivery combination products (especially respiratory) device technology. This has led to involvement in projects with focus in pulmonary, nasal and other delivery routes, with an international client base. Much of the activity of PharmaDelivery Solutions Ltd is focused in the area of development programme support, regulatory GAP analysis and generation of documentation supporting development and test programmes, together with data review and contingency evaluation.

David has over 35 years experience in the development, industrialization and approval of inhalation drug delivery systems, combination products and medical devices.

PharmaDelivery Solutions Ltd has provided input ranging from GAP analysis and comment to complete remedial implementation in areas including

• Design Control
• Risk Management
• Materials strategies
• Regulatory documentation
• Technical reviews and opinion

In addition to activities supporting commercial organizations, David has been involved in the following roles;

Honorary Teaching Fellow in the School of Pharmacy and Pharmaceutical Sciences at the University of Manchester and is author/ tutor for the Pharmaceutical Industry Advanced Training (PIAT) MSc module on Inhalation dosage forms.

A UK national expert representing the British Standards Institute on ISO TC84 developing new international standards for pulmonary and nasal delivery devices syringes and catheters.

David has also worked with the United Nations and various national governments to develop and establish transition strategies from the use of CFC in Metered Dose Inhalers and to secure appropriate budgets from the Multi-lateral fun for the implementation of the Montreal Protocol in emerging markets around the world.

Book now

Book now

16-17 Feb 2021
Live webinar
16-17 Feb 2021
Live webinar
GBP 1,099.00
EUR 1,579.00
USD 1,786.00
Until 5 Jan 21*
Enrol now
to attend
Live webinar
18-19 Feb 2021
Face-to-face, (venue not yet confirmed)
18-19 Feb 2021
Face-to-face
(venue not yet confirmed)
GBP 1,299.00
EUR 1,819.00
USD 2,026.00
Until 7 Jan 21*
Enrol now
to attend
Face-to-face
(venue not yet confirmed)
  • 2 days of classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy
13-14 Sep 2021
Face-to-face, (venue not yet confirmed)
13-14 Sep 2021
Face-to-face
(venue not yet confirmed)
GBP 1,299.00
EUR 1,819.00
USD 2,026.00
Until 2 Aug 21*
Enrol now
to attend
Face-to-face
(venue not yet confirmed)
  • 2 days of classroom-based training
  • Meet presenters and fellow attendees in person
  • Lunch and refreshments provided
  • Download documentation and certification of completion
  • Fair transfer and cancellation policy
15-16 Sep 2021
Live webinar
15-16 Sep 2021
Live webinar
GBP 1,099.00
EUR 1,579.00
USD 1,786.00
Until 4 Aug 21*
Enrol now
to attend
Live webinar

Learn more about our face-to-face and webinar training formats.

* Note the early booking discount cannot be combined with any other offers or promotional code

Customised in-house training

We can customise this course to meet the requirements of your organisation and deliver it at your location and/or online.

Contact us

You may also be interested in

Previous customers include...

  • Avillion LLP
  • Delim Cosmetics & Pharma s.r.l.
  • Geolab Pharmaceutical Industry
  • MHRA
  • Presspart
  • Presspart Manufacturing Ltd
  • QA Ltd
  • RPC Formatec GmbH
  • STADA Arzneimittel AG
  • Tabuk Pharmaceutical Research Co.
  • Teva Pharmaceuticals Ireland
  • Vectura

I was hoping for further improvement of my understanding of the matter of inhalational drugs, especially MDI, and this expectation was fully met. The speakers had superb knowledge of the subject, vast experience and a great sense of humour.

Robin Boehm, Team Leader Regulatory Submissions - New Products, STADA Arzneimittel AG, Sep 19

Very good course for those who has no previous experience in this Topic...Thanks to the organisers.

Sami Qassim, Senior Vice President , Tabuk Pharmaceutical Research Co., Feb 19

In general good for content and presentation.

Celestino Ronchi, President, Delim Cosmetics & Pharma s.r.l., Feb 19